given that the announcement gives the value of TBI in 2027, I'll assume that's when they are aiming for commercial entry. That tells me that they are thinking of a Ph2 in 2024, ph3 in 25/26 and 6-12 months to navigate regulatory bodies....
in the medium term, we could have ph3 iih readout close to a ph2 TBI. could be a blockbuster
